Cargando…
THU596 Heteromerization Of The Angiotensin II Type 1 Receptor And The Bradykinin Type 2 Receptor
Disclosure: E.K. Johnstone: Grant Recipient; Self; Australian Research Council. K.D. Pfleger: Grant Recipient; Self; Australian Research Council. Stock Owner; Self; Dimerix Bioscience Pty Ltd. Background: Receptor heteromerization is the phenomenon whereby two different receptors form a functional c...
Autores principales: | Johnstone, Elizabeth K M, Pfleger, Kevin D G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554900/ http://dx.doi.org/10.1210/jendso/bvad114.593 |
Ejemplares similares
-
Novel Pharmacology Following Heteromerization of the Angiotensin II Type 2 Receptor and the Bradykinin Type 2 Receptor
por: Johnstone, Elizabeth K. M., et al.
Publicado: (2022) -
FRI126 Autoreactive T Cells To Angiotensin II Type 1 Receptor In Salt-dependent Hypertension Due To Primary Aldosteronism
por: Scarpa, Riccardo, et al.
Publicado: (2023) -
Insights into the Interaction of LVV-Hemorphin-7 with Angiotensin II Type 1 Receptor
por: Ali, Amanat, et al.
Publicado: (2020) -
Receptor-Heteromer Investigation Technology and its application using BRET
por: Johnstone, Elizabeth K. M., et al.
Publicado: (2012) -
Heteromerization fingerprints between bradykinin B2 and thromboxane TP receptors in native cells
por: Dagher, Oula K., et al.
Publicado: (2019)